Cemiplimab
ATC L01FF06 · 8 markets · 13 records
Cemiplimab
Forms
AU 3 records · 3 strengths
- 350 mg/7 mLinjectionLIBTAYO
- 350 mginjectionLIBTAYO cemiplimab 350 mg concentrate for solution for infusion
Records without a stated strength · 1 LIBTAYO
US 2 records · 2 strengths
- 350 mg/7 mLinjectionNo trade name
- 50 mginjectionLIBTAYO
GB 1 records · 1 strengths
- 350 mg/7 mLinjectionLibtayo 350mg/7ml concentrate for solution for infusion vials
CA 1 records · 1 strengths
- 50 mg/1 mLliquidLIBTAYO
ES 1 records · 1 strengths
- 50 mg/1 mLinjectionLIBTAYO
MX 1 records · 1 strengths
Records without a stated strength · 1 LIBTAYO
TW 1 records · 1 strengths
Records without a stated strength · 1 Libtayo concentrate for solution for infusion、力汰瘤濃縮輸注液
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 LIBTAYO
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.